Keri concentrates her practice on complex patent cases for clients in the pharmaceutical and biotechnology industries. She is a registered patent attorney and represents pharmaceutical companies in Hatch-Waxman and biosimilar litigation.
Prior to attending law school, Keri received her Ph.D. in immunology from Wayne State University School of Medicine where, as a part of her doctoral research, she studied human CD8+ T cell responses to HIV epitopes and mimotopes thereof. Keri then completed a postdoctoral fellowship at the University of Michigan where she examined the role of transforming growth factor-β (TGF-β) in natural killer (NK) cell maturation. Keri has been published in numerous immunology journals.
Keri is also a graduate of Loyola University Chicago School of Law, and earned a bachelor’s degree in biology and anthropology from the University of Michigan.